Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
ICMR
Eligibility
Inclusion criteria
Inclusion criteria: All consenting HCWs with laboratory confirmation of COVID-19 infection including asymptomatic cases, working in ICMR RUMC institutions who have recovered (been declared ââ?¬Ë?dischargedââ?¬•) as per MoHFW guidelines 12 to 52 weeks ago.
Exclusion criteria
Exclusion criteria: 1. Any serious co-morbid medical or mental health condition that would make the subject unable to participate in the study. 2. Pregnancy
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Occurrence of medical sequelae following COVID-19 infection among the HCWs who have taken hydroxychloroquine prophylaxis versus HCWs who have not taken hydroxychloroquine prophylaxis. 2. Prevalence of vaccination hesitancy and factors associated with it.Timepoint: In this study, data collection from HCWs who had recovered (ââ?¬Ë?dischargedââ?¬â?¢) from COVID-19 12 to 52 weeks ago. | — |
Primary
| Measure | Time frame |
|---|---|
| 1. Estimation of prevalence of persistent symptoms in recovered COVID-19 HCWs. 2. Estimation of the associated with the medical sequelae in recovered COVID-19 HCWs.Timepoint: In this study, data collection from HCWs who had recovered (ââ?¬Ë?dischargedââ?¬â?¢) from COVID-19 12 to 52 weeks ago. | — |
Countries
India
Contacts
Public ContactDr Shubham Atal
Department of Pharmacology, AIIMS, Bhopal, M.P.
Outcome results
None listed